Tricol Biomedical, Inc., formerly dba HemCon Medical Technologies, Inc. is now a wholly owned subsidiary of Tricol International Group, Ltd., itself part of Weifang Tricol Trading Co. Ltd. Tricol Biomedical, Inc. is structured around development of high performing advanced wound care, hemorrhage, infection control & wound management technologies. The firm is continuing to carry HemCons mission and brand of life savings chitosan and oxidized cellulose based hemostatic solutions worldwide with a variety of innovative technologies, platforms, and products serving the professional, military, and consumer medical markets.
